Nference’s biomedical knowledge synthesis platform uses AI to compile vast amounts of healthcare data, making the information more accessible for the research, development and operational processes of the company’s biopharmaceutical partners.
“Our strategic investment in Nference is a reflection of our confidence that a holistic knowledge synthesis platform that puts patient privacy first is the solution for effectively leveraging real-world evidence to spur innovation to benefit patient care,” Andrew Danielsen, chair of Mayo Clinic Ventures, said in the release.
More articles on AI:
Merck innovation fund joins Cigna, Celgene in $28M precision medicine AI funding
Michigan Medicine AI boosts accuracy, precision of brain tumor diagnosis
Banner Health integrates AI-powered digital triage tool to improve patient experience
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
